A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinoma
Fumihiko Urabe(Jikei University School of Medicine), Tatsuya Shimomura(Jikei University School of Medicine), Keigo Sakanaka(Jikei University School of Medicine), Kojiro Tashiro(Jikei University School of Medicine), Yu Imai(Jikei University School of Medicine), Takahiro Kimura(Jikei University School of Medicine), Katsuki Muramoto(Jikei University School of Medicine), Yuma Goto(Jikei University School of Medicine), Soshi Kadena(Jikei University School of Medicine), Hajime Onuma(Jikei University School of Medicine), Kosuke Iwatani(Jikei University School of Medicine)
Cited by 1
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
|Clinical Cancer Research|2019|129
Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications
|Experimental & Molecular Medicine|2019|112
Extracellular vesicles in the development of organ‐specific metastasis
|Journal of Extracellular Vesicles|2021|101